Add time:08/02/2019         Source:sciencedirect.com

BackgroundEffective targeting therapies for common chronic liver disease nonalcoholic steatohepatitis (NASH) are in urgent need. MicroRNA-targeted therapeutics would be potentially an effective treatment strategy of hepatic diseases. Here we investigated the functional role of miR-221/222 and the therapeutic effects of antimiRs-221/222 in NASH mouse models.

We also recommend Trading Suppliers and Manufacturers of Acid Blue 221 (cas 12219-32-8). Pls Click Website Link as below: cas 12219-32-8 suppliers